Search
Bausch + Lomb Corp
BLCOAdd to Watchlist
16.540USD
-0.090-0.54%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.86BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-29The current earnings forecast score of Bausch + Lomb Corp is 6.62, ranking 163 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 17.00, with a high of 21.00 and a low of 13.00.
Analyst Rating
Based on
12
analysts
Hold
Current Rating
18.091
Target Price
+8.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Bausch + Lomb Corp
BLCO
12
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Bausch + Lomb Corp's expected revenue for the next quarter?
Bausch + Lomb Corp's expected revenue is 1.37B.
What is Bausch + Lomb Corp's price target?
Analysts forecast that Bausch + Lomb Corp's price target is USD 17.00, with the highest forecast at USD 21.00 and the lowest forecast at USD 13.00.
How have Bausch + Lomb CorpBLCO's recent earnings per share performed?
The market expectation was USD -0.20, while Bausch + Lomb CorpBLCO's earnings per share (EPS) for the previous quarter was USD -0.16. EPS for the next quarter is expected at USD 0.15.
What is the analyst rating for Bausch + Lomb Corp?
Based on the ratings of Bausch + Lomb Corp's stock from 12 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
